Extrafine beclometasone/LABD formulations did not increase pneumonia risk versus LABD
Date
2024-03-26
Journal Title
Journal ISSN
Volume Title
Publisher
Citation
Singh, D, Price, D, Henley, W, Delfini Cançado, J E, Fabbri, L M, Kerstjens, H AM, Papi, A, Roche, N, Şen, E, Vogelmeier, C F, Nudo, E, Carter, V, Skinner, D, Vella, R, Soriano, J B, Kots, M & Georges, G 2024, 'Extrafine beclometasone/LABD formulations did not increase pneumonia risk versus LABD', TSANZSRS 2024, Gold Coast, Australia, 23/03/24 - 26/03/24.
conference
conference